...
首页> 外文期刊>Indian journal of clinical biochemistry: IJCB >Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome
【24h】

Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome

机译:肌酸(磷酸)激酶,CK-MB同工酶在印度急性冠状动脉综合征诊断中的异常活动测定

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, the cause of suspected false-positive (anomalous) values for CK-MB activity, in Indian patients investigated for ACS, Total serum CK and CK-MB activity, serum Troponin I were measured and CK-MB as a percentage of the total CK activity (%CK-MB) calculated, CK-MB was also estimated using densitometry and CK-MB mass assay, Anomalous specimens were tested for the presence of CK isoenzymes, In 22 healthy subjects," 11 male and female, the %CK-MB ranged from 3.6 to 30.2, In 11 male patients, with proven ACS, the %CK-MB was from 4.0 to 17.5, The cut off for anomalous CK-MB activity values was set as >33.0%, In 35 patients with anomalies, total CK values ranged from 39 to 231 U/L, CK-MB from 30 to 161 U/L, Investigation of CK isoenzymes, showed 10 patients had a CK-BB band, 14 an intermediate band between CK-MM and CK-MB (macro-CK type 1), 7 had a cathodal band (macro-CK type 2), and 3 had a band intermediate between CK-MB and CK-BB, This later band does not seem to have been previously reported, Against the CK-MB mass assay, the activity assay showed no correlation, in 43 patients (19 M, 24 F), Pearson coefficient (R2) was 0.006, The CK-MB immunoinhibition assay is better described as measuring "non-CK-MM activity." A %CK-MB activity >6% as a marker of ACS is not valid in our patient population, Laboratories should not use only CK-MB activity as a biochemical marker of ACS.
机译:在本研究中,对CK-MB活性怀疑为假阳性(异常)值的原因进行了调查,在接受ACS调查的印度患者中,测量了血清CK和CK-MB的总活性,测量了血清肌钙蛋白I,并以百分比形式显示了CK-MB在计算的总CK活性(%CK-MB)中,还使用光密度测定法和CK-MB质量测定法估算了CK-MB。测试了异常样本中CK同工酶的存在。在22位健康受试者中,“ 11位男性和女性, %CK-MB范围从3.6到30.2,在11位经ACS证实的男性患者中,%CK-MB范围从4.0到17.5,CK-MB异常活动值的临界值设置为> 33.0%,在35异常患者,总CK值范围为39至231 U / L,CK-MB为30至161 U / L,对CK同工酶的调查显示10例患者有CK-BB带,14例介于CK-MM之间和CK-MB(宏CK型1),7个具有阴极带(宏CK 2型),而3个具有介于CK-MB和CK-BB之间的带,这后面的带似乎没有根据先前的报道,针对CK-MB质谱分析,活性分析显示无相关性,在43例患者(19 M,24 F)中,皮尔森系数(R2)为0.006,CK-MB免疫抑制分析更好地描述为“ “%CK-MB活性> 6%作为ACS的标志物在我们的患者人群中无效,实验室不应仅将CK-MB活性用作ACS的生化标志物。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号